Stock fact sheet · data as of
LeMaitre Vascular, Inc. (LMAT): fair value, margin of safety and Wheel Score
Healthcare · Medical - Instruments & Supplies · United States · High Growth
Is LMAT undervalued?
At 83.16 (close of 16 Oct 2026), LMAT trades 13% over the GLS average fair value of 73.78. 4 of the 9 models land above the price and 5 below. A negative margin of safety costs Value points in the Wheel Score (7 of 25 here) - the models see no discount, which does not make the business a poor one, only the price a full one.
The 9 models disagree widely: DDM gives 13.98 while GLS Growth gives 175.89. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.
The nightly engine files LMAT under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.
Nine valuation models for LMAT
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 89.35 | +7% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 34.48 | -59% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 78.76 | -5% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 28.07 | -66% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 175.89 | +112% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 83.68 | +1% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 127.89 | +54% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | 13.98 | -83% | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend |
| EPV | 31.92 | -62% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 10.76 | -87% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 115.00 | +38% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is average - LMAT passes 6 of the nine Piotroski tests, which passes the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is 8.1 out of 10, built from ten years of revenue, earnings, margins, cash flow, share count and returns on capital scored for consistency - a high reading that points to a durable business.
Returns on capital are moderate - ROIC 10.0%, ROE 14.7%, ROA 9.4% - with debt at 0.47 times equity and a free-cash-flow yield of 3.9%.
The dividend yield is 1.14% with a payout ratio of 31% - a small yield that leaves most of the earnings in the business. Revenue comes mainly from Operating Segments 100% (quarter Q3 FY2025).
Institutional ownership scores 10/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 10.0% |
|---|---|---|---|
| GLS Moat | 8.1 / 10 | ROE | 14.7% |
| Debt / equity | 0.47 | ROA | 9.4% |
| Free-cash-flow yield | 3.9% | Payout ratio | 31% |
| Institutions | 10 / 10 | Insiders · Congress | 10 · 5 / 10 |
Wheel Score 65: Good
LMAT scores 65 out of 100 on the Wheel Score (Good band, 65-79). The score blends the margin of safety (Value, 7/25), Piotroski health (13/20), the GLS moat (12/15), the option premium on offer (20/20) and how easily the stock trades (12/20). Value (7/25) is the part holding the score back.
Implied volatility is 52% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is thin - 937 contracts across every expiry - so fills at a fair price are not guaranteed; a 30-45-day put may not exist at a usable strike.
Volume runs at 298k shares a day on a market cap of $1.9B, with a beta of 0.47 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 12 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 7 / 25 | -13% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 12 / 15 | moat 8.1/10 | |
| Premium | 20 / 20 | implied volatility 52% | |
| Stability | 12 / 20 | 298k shares/day, $1.9B cap, beta 0.47 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 4 Nov 2026 (after the close), 19 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Instruments & Supplies
The 12 companies below are the closest to LeMaitre Vascular, Inc. by market cap within the Medical - Instruments & Supplies industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies, Ltd. | 28.68 | - | - | 34No options | $1.7B |
| XRAY DENTSPLY SIRONA Inc. | 8.44 | 17.78 | +53% | 45Weak | $1.7B |
| AZTA Azenta, Inc. | 36.52 | 10.35 | -253% | 45Weak | $1.6B |
| ATRC AtriCure, Inc. | 57.78 | 12.55 | -361% | 58Fair | $2.9B |
| STAA STAAR Surgical Company | 21.84 | 2.47 | -783% | 45Weak | $1.1B |
| PLSE Pulse Biosciences, Inc. | 46.32 | 1.06 | -4275% | 38Weak | $3.3B |
| NVST Envista Holdings Corp | 23.50 | 20.52 | -15% | 65Good | $3.8B |
| ICUI ICU Medical, Inc. | 167.23 | 60.82 | -175% | 50Fair | $4.2B |
| TFX Teleflex Incorporated | 123.29 | 85.49 | -44% | 45Weak | $5.2B |
| STVN Stevanato Group S.p.A. | 19.31 | 10.82 | -79% | 58Fair | $5.3B |
| MMSI Merit Medical Systems, Inc. | 89.57 | 65.92 | -36% | 59Fair | $5.3B |
| BLCO Bausch + Lomb Corporation | 16.66 | 10.95 | -52% | 45Weak | $6.0B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about LMAT
Is LMAT undervalued right now?
No: at 83.16 the stock trades 13% above the GLS average fair value of 73.78 (data as of 16 Oct 2026). The margin of safety is negative.
What is the Wheel Score of LMAT and what does it mean?
LMAT scores 65 out of 100 (Good). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for LMAT?
73.78 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does LeMaitre Vascular, Inc. report earnings next?
The next earnings report is due on 4 Nov 2026 (after the close), 19 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does LMAT have listed options, and how liquid are they?
Yes. The nightly snapshot found 196 listed contracts with 937 open interest across all expiries and implied volatility of 52% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.